David Ricks, Eli Lilly CEO (AP Photo/Carolyn Kaster)

Eli Lil­ly sues com­pounders and med­ical spas over sales of un­ap­proved copy­cats of its di­a­betes block­buster Moun­jaro

Eli Lil­ly on Tues­day sued 10 med­ical spas, well­ness cen­ters and com­pound­ing phar­ma­cies in Flori­da, Geor­gia, Ari­zona, Min­neso­ta, Utah and Texas for sell­ing un­ap­proved and com­pound­ed ver­sions of its block­buster type 2 di­a­betes drug Moun­jaro (tirzepatide).

Lil­ly is ask­ing the de­fen­dants, sev­er­al of whom use an unau­tho­rized Moun­jaro trade­mark on their web­sites, to stop pro­vid­ing drugs in vi­o­la­tion of con­sumer pro­tec­tion laws. The com­pa­ny notes height­ened safe­ty con­cerns, say­ing some of these com­pa­nies promise their pa­tients that the drugs of­fer the same safe­ty pro­file and clin­i­cal ben­e­fits as Moun­jaro when they’re ac­tu­al­ly com­pound­ed ver­sions that don’t ad­here to the same FDA reg­u­la­tions as ful­ly ap­proved prod­ucts.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Senior Associate

Alexandria Real Estate Equities

Durham, NC, USA